Skip to main content

AI for NZ Healthcare

AI in NZ healthcare: the opportunities, the risks, the sovereignty requirements. What's actually possible today.
5 October 2023·6 min read
Dr Tania Wolfgramm
Dr Tania Wolfgramm
Chief Research Officer
Isaac Rolfe
Isaac Rolfe
Managing Director
New Zealand's health system is under pressure. Workforce shortages, rising demand, administrative burden. AI offers real potential to address some of these challenges. But health is a domain where getting AI wrong has consequences that go far beyond a bad quarterly report.

The Opportunity

The opportunities for AI in NZ healthcare are specific and, in some cases, substantial.
Administrative automation. Clinicians in New Zealand spend a significant portion of their time on documentation, coding, and administrative tasks. AI can draft clinical notes from consultations, automate coding for billing and reporting, and handle routine correspondence. This isn't glamorous. It's practical, and it gives clinicians back time for clinical work.
Clinical decision support. AI systems that surface relevant clinical guidelines, flag potential drug interactions, or identify patients who may need earlier intervention. Not replacing clinical judgement - augmenting it with information the clinician might not have immediately at hand.
Population health. Analysing patterns across patient populations to identify emerging health trends, predict demand, and allocate resources. New Zealand's relatively integrated health data (compared to fragmented systems in other countries) creates an advantage here.
Triage and routing. AI-assisted triage that helps direct patients to the right level of care more efficiently. Particularly relevant for telehealth and after-hours services.
30-40%
of clinician time estimated to be spent on administrative and documentation tasks across NZ health services
Source: NZ Medical Association, Workforce Survey, 2023

The Risks

Bias in Clinical AI

AI systems trained on global clinical datasets inherit the biases of those datasets. These datasets are predominantly drawn from European and North American populations. Clinical AI that performs well on these populations may perform differently on Māori, Pacific, and Asian populations that make up a significant proportion of New Zealand's health consumers.
This is not a theoretical concern. Dermatology AI has been shown to underperform on darker skin tones. Cardiac risk models calibrated to European populations produce different risk profiles for Māori and Pacific patients. Any clinical AI deployed in Aotearoa needs to be validated against the population it will serve.

Cultural Appropriateness

Health and wellbeing are understood differently across cultures. Te Whare Tapa Wha, the Māori health model, encompasses wairua (spiritual), hinengaro (mental/emotional), tinana (physical), and whanau (family/social) dimensions. An AI health system grounded only in Western biomedical models is incomplete in a New Zealand context.
Tania: This is not about adding cultural content to a Western system. It is about recognising that health itself is a culturally situated concept, and that AI systems which encode only one cultural understanding of health will produce recommendations that are culturally incomplete for a significant portion of the population they serve.

Data Sovereignty

Health data is among the most sensitive categories of personal information. In a New Zealand context, health data about Māori is subject to Māori data sovereignty principles. Processing this data through offshore AI systems raises governance questions that existing health information frameworks were not designed to address.
Isaac: The practical challenge is stark. The best AI models are hosted offshore. The most sensitive health data should stay onshore. Bridging this gap requires either sovereign AI infrastructure or a hybrid architecture that routes sensitive data to local processing. Neither option is trivial, but both are achievable.

What's Possible Today

Let me be honest about the current state.
Available now: Administrative AI - documentation, coding, correspondence. These are mature use cases with proven technology and manageable risk.
Emerging: Clinical decision support for well-defined, lower-risk applications. Drug interaction checking. Guideline surfacing. Appointment scheduling and triage assistance.
Not yet ready: Diagnostic AI in production clinical settings. Complex clinical reasoning. Any application where the AI's output directly drives clinical decisions without human review.
The temptation is to pursue the most exciting applications. The pragmatic approach is to start with the highest-value, lowest-risk use cases and build capability, trust, and governance incrementally.
NZ Healthcare AI Readiness by Use Case
Source: RIVER Group Assessment, 2023

What Needs to Happen

Validation frameworks. Before any clinical AI is deployed in New Zealand, it needs to be validated against NZ populations, including Māori and Pacific patients. This requires local clinical data, local clinical expertise, and local governance.
Sovereignty infrastructure. NZ needs the infrastructure to process sensitive health data through AI systems within our jurisdiction. This is a national investment, not an individual DHB decision.
Cultural governance. Māori and Pacific communities should be involved in the governance of AI systems that use their health data or serve their communities. This is both a Te Tiriti obligation and good design practice.
Workforce development. Clinicians need AI literacy. Not technical skills, but the ability to evaluate AI outputs, understand limitations, and integrate AI tools into clinical workflows effectively.
Incremental deployment. Start with administrative AI. Build trust and capability. Expand to clinical support. Measure everything. Move thoughtfully.